{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:27:51Z","timestamp":1781018871063,"version":"3.54.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11514-6","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:18:54Z","timestamp":1770124734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A comprehensive analysis of epigenetic mechanisms regulating inflammation-induced TNF-\u03b1 gene expression by small-molecule inhibitor screening"],"prefix":"10.1007","volume":"53","author":[{"given":"Komal Paresh","family":"Walvekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Balaji","family":"Andugulapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabarinadh","family":"Chilaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"11514_CR1","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","volume":"72","author":"EA Carswell","year":"1975","unstructured":"Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 72:3666\u20133670","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11514_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155066","volume":"130","author":"P Mahdavi Sharif","year":"2020","unstructured":"Mahdavi Sharif P, Jabbari P, Razi S, Keshavarz-Fathi M, Rezaei N (2020) Importance of TNF-alpha and its alterations in the development of cancers. Cytokine 130:155066","journal-title":"Cytokine"},{"key":"11514_CR3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.canlet.2012.10.014","volume":"328","author":"WM Chu","year":"2013","unstructured":"Chu WM (2013) Tumor necrosis factor. Cancer Lett 328:222\u2013225","journal-title":"Cancer Lett"},{"key":"11514_CR4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nri1184","volume":"3","author":"BB Aggarwal","year":"2003","unstructured":"Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3:745\u2013756","journal-title":"Nat Rev Immunol"},{"key":"11514_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","volume":"19","author":"M Feldmann","year":"2001","unstructured":"Feldmann M, Maini RN (2001) Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 19:163\u2013196","journal-title":"Annu Rev Immunol"},{"key":"11514_CR6","unstructured":"Meager A, Wadhwa MA Overview of Cytokine Regulation of Inflammation and Immunity; in eLS"},{"key":"11514_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000087104","volume":"12","author":"IJ Elenkov","year":"2005","unstructured":"Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP (2005) Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12:255\u2013269","journal-title":"Neuroimmunomodulation"},{"key":"11514_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/jir.2019.0085","volume":"40","author":"KK Gupta","year":"2020","unstructured":"Gupta KK, Khan MA, Singh SK (2020) Constitutive inflammatory cytokine storm: a major threat to human health. J Interferon Cytokine Res 40:19\u201323","journal-title":"J Interferon Cytokine Res"},{"key":"11514_CR9","doi-asserted-by":"crossref","unstructured":"Jang DI, Lee AH (2021) The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics. Int J Mol Sci 22:2719.","DOI":"10.3390\/ijms22052719"},{"key":"11514_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/03946320140270S101","volume":"27","author":"C Blandizzi","year":"2014","unstructured":"Blandizzi C, Gionchetti P, Armuzzi A et al (2014) The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases. Int J Immunopathol Pharmacol 27:1\u201310","journal-title":"Int J Immunopathol Pharmacol"},{"key":"11514_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10","volume":"20","author":"N Parameswaran","year":"2010","unstructured":"Parameswaran N, Patial S (2010) Tumor necrosis factor-\u03b1 signaling in macrophages. Crit Rev Eukaryot Gene Expr 20:87\u2013103","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"11514_CR12","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S0962-8924(01)02064-5","volume":"11","author":"V Baud","year":"2001","unstructured":"Baud V, Karin M (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11:372\u2013377","journal-title":"Trends Cell Biol"},{"key":"11514_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1360\/02yc9013","volume":"45","author":"J Zha","year":"2002","unstructured":"Zha J, Shu H (2002) Molecular mechanism of signaling by tumor necrosis factor. Sci China Life Sci 45:113\u2013119","journal-title":"Sci China Life Sci"},{"key":"11514_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/path.2287","volume":"214","author":"JR Bradley","year":"2008","unstructured":"Bradley JR (2008) TNF-mediated inflammatory disease. J Pathol 214:149\u2013160","journal-title":"J Pathol"},{"key":"11514_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.smim.2014.02.009","volume":"26","author":"G Sabio","year":"2014","unstructured":"Sabio G, Davis RJ (2014) TNF and MAP kinase signalling pathways. Semin Immunol 26:237\u2013245","journal-title":"Semin Immunol"},{"key":"11514_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.immunol.23.021704.115806","volume":"23","author":"T Kishimoto","year":"2005","unstructured":"Kishimoto T (2005) Interleukin-6: from basic science to medicine\u201340 years in immunology. Annu Rev Immunol 23:1\u201321","journal-title":"Annu Rev Immunol"},{"key":"11514_CR17","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1369\/jhc.6A7171.2007","volume":"55","author":"Y Sawa","year":"2007","unstructured":"Sawa Y, Sugimoto Y, Ueki T et al (2007) Effects of TNF-alpha on leukocyte adhesion molecule expressions in cultured human lymphatic endothelium. J Histochem Cytochem 55:721\u2013733","journal-title":"J Histochem Cytochem"},{"key":"11514_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.0906-6705.2004.00205.x","volume":"13","author":"AJ Schottelius","year":"2004","unstructured":"Schottelius AJ, Moldawer LL, Dinarello CA, Asadullah K, Sterry W, Edwards CK 3rd (2004) Biology of tumor necrosis factor-alpha- implications for psoriasis. Exp Dermatol 13:193\u2013222","journal-title":"Exp Dermatol"},{"key":"11514_CR19","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","volume":"343","author":"PE Lipsky","year":"2000","unstructured":"Lipsky PE, van der Heijde DM, St Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N Engl J Med 343:1594\u20131602","journal-title":"N Engl J Med"},{"key":"11514_CR20","doi-asserted-by":"crossref","unstructured":"Leone GM, Mangano K (2023) Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy. 12:1630","DOI":"10.3390\/jcm12041630"},{"key":"11514_CR21","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295:2275\u20132285","journal-title":"JAMA"},{"key":"11514_CR22","doi-asserted-by":"crossref","unstructured":"Singh JA, Wells GA, Christensen R et al (2011) Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev 2011, Cd008794","DOI":"10.1002\/14651858.CD008794"},{"key":"11514_CR23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2217\/imt.10.67","volume":"2","author":"LC Silva","year":"2010","unstructured":"Silva LC, Ortigosa LC, Benard G (2010) Anti-TNF-\u03b1 agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. Immunotherapy 2:817\u2013833","journal-title":"Immunotherapy"},{"key":"11514_CR24","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/art.20982","volume":"52","author":"JS Smolen","year":"2005","unstructured":"Smolen JS, Han C, Bala M et al (2005) Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis Rheum 52:1020\u20131030","journal-title":"Arthritis Rheum"},{"key":"11514_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson MA, Kouzarides T (2012) Cancer epigenetics: from mechanism to therapy. Cell 150:12\u201327","journal-title":"Cell"},{"key":"11514_CR26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrg.2016.59","volume":"17","author":"CD Allis","year":"2016","unstructured":"Allis CD, Jenuwein T (2016) The molecular hallmarks of epigenetic control. Nat Rev Genet 17:487\u2013500","journal-title":"Nat Rev Genet"},{"key":"11514_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T (2011) Regulation of chromatin by histone modifications. Cell Res 21:381\u2013395","journal-title":"Cell Res"},{"key":"11514_CR28","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1063127","volume":"293","author":"T Jenuwein","year":"2001","unstructured":"Jenuwein T, Allis CD (2001) Translating the histone code. Science 293:1074\u20131080","journal-title":"Science"},{"key":"11514_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nexres.2025.100656","volume":"2","author":"W Komal Paresh","year":"2025","unstructured":"Komal Paresh W, Sreeja V, Sai Balaji A, Sabarinadh C (2025) Stable expression of human arginase 1 does not suppress inflammation or M1 macrophage polarization in THP-1 monocytes. Next Research 2:100656","journal-title":"Next Research"},{"key":"11514_CR30","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/nature09589","volume":"468","author":"E Nicodeme","year":"2010","unstructured":"Nicodeme E, Jeffrey KL, Schaefer U et al (2010) Suppression of inflammation by a synthetic histone mimic. Nature 468:1119\u20131123","journal-title":"Nature"},{"key":"11514_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-022-01380-6","volume":"20","author":"M Ghiboub","year":"2022","unstructured":"Ghiboub M, Koster J, Craggs PD et al (2022) Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140. BMC Biol 20:182","journal-title":"BMC Biol"},{"key":"11514_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2174\/0118715230294413240415054610","volume":"23","author":"P Sharma","year":"2024","unstructured":"Sharma P, Venkatachalam K, Binesh A (2024) Decades long involvement of THP-1 cells as a model for macrophage research: a comprehensive review. Antiinflamm Antiallergy Agents Med Chem 23:85\u2013104","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"11514_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008668","volume":"5","author":"M Daigneault","year":"2010","unstructured":"Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH (2010) The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One 5:e8668","journal-title":"PLoS One"},{"key":"11514_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-8-1","volume":"8","author":"O Sharif","year":"2007","unstructured":"Sharif O, Bolshakov VN, Raines S, Newham P, Perkins ND (2007) Transcriptional profiling of the LPS induced NF-kappaB response in macrophages. BMC Immunol 8:1","journal-title":"BMC Immunol"},{"key":"11514_CR35","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s12013-024-01235-7","volume":"82","author":"L Becker","year":"2024","unstructured":"Becker L, Holtmann D (2024) Anti-inflammatory effects of \u03b1-humulene on the release of pro-inflammatory cytokines in lipopolysaccharide-induced THP-1 cells. Cell Biochem Biophys 82:839\u2013847","journal-title":"Cell Biochem Biophys"},{"key":"11514_CR36","doi-asserted-by":"publisher","first-page":"34611","DOI":"10.1038\/srep34611","volume":"6","author":"L Yang","year":"2016","unstructured":"Yang L, Guo H, Li Y et al (2016) Oleoylethanolamide exerts anti-inflammatory effects on LPS-induced THP-1 cells by enhancing PPAR\u03b1 signaling and inhibiting the NF-\u03baB and ERK1\/2\/AP-1\/STAT3 pathways. Sci Rep 6:34611","journal-title":"Sci Rep"},{"key":"11514_CR37","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M (2023) The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51:D638-d646","journal-title":"Nucleic Acids Res"},{"key":"11514_CR38","doi-asserted-by":"publisher","first-page":"d12","DOI":"10.2741\/A171","volume":"2","author":"CA Feghali","year":"1997","unstructured":"Feghali CA, Wright TM (1997) Cytokines in acute and chronic inflammation. Front Biosci 2:d12\u201326","journal-title":"Front Biosci"},{"key":"11514_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230884","volume":"15","author":"B Rhead","year":"2020","unstructured":"Rhead B, Shao X, Quach H, Ghai P, Barcellos LF, Bowcock AM (2020) Global expression and CpG methylation analysis of primary endothelial cells before and after TNFa stimulation reveals gene modules enriched in inflammatory and infectious diseases and associated dmrs. PLoS One 15:e0230884","journal-title":"PLoS One"},{"key":"11514_CR40","doi-asserted-by":"crossref","unstructured":"Rider P, Carmi Y, Cohen I (2016) Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations. 2016, 9259646","DOI":"10.1155\/2016\/9259646"},{"key":"11514_CR41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1126\/science.1230720","volume":"339","author":"I Tabas","year":"2013","unstructured":"Tabas I, Glass CK (2013) Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 339:166\u2013172","journal-title":"Science"},{"key":"11514_CR42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1136\/annrheumdis-2012-202545","volume":"72","author":"FB Vincent","year":"2013","unstructured":"Vincent FB, Morand EF, Murphy K, Mackay F, Mariette X, Marcelli C (2013) Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective. Ann Rheum Dis 72:165\u2013178","journal-title":"Ann Rheum Dis"},{"key":"11514_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen S, Saeed AFUH, Liu Q et al (2023) Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther 8:207","journal-title":"Signal Transduct Target Ther"},{"key":"11514_CR44","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fimmu.2014.00491","volume":"5","author":"G Arango Duque","year":"2014","unstructured":"Arango Duque G, Descoteaux A (2014) Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol 5:491","journal-title":"Front Immunol"},{"key":"11514_CR45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fimmu.2014.00071","volume":"5","author":"D Bhatt","year":"2014","unstructured":"Bhatt D, Ghosh S (2014) Regulation of the NF-\u03baB-mediated transcription of inflammatory genes. Front Immunol 5:71","journal-title":"Front Immunol"},{"key":"11514_CR46","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/jcp.26010","volume":"233","author":"JT Lloyd","year":"2018","unstructured":"Lloyd JT, Glass KC (2018) Biological function and histone recognition of family IV bromodomain-containing proteins. J Cell Physiol 233:1877\u20131886","journal-title":"J Cell Physiol"},{"key":"11514_CR47","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1177\/0022034514534261","volume":"93","author":"S Meng","year":"2014","unstructured":"Meng S, Zhang L, Tang Y et al (2014) BET inhibitor JQ1 blocks inflammation and bone destruction. J Dent Res 93:657\u2013662","journal-title":"J Dent Res"},{"key":"11514_CR48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/eji.201444862","volume":"45","author":"CH Chan","year":"2015","unstructured":"Chan CH, Fang C, Yarilina A, Prinjha RK, Qiao Y, Ivashkiv LB (2015) BET bromodomain inhibition suppresses transcriptional responses to cytokine-Jak-STAT signaling in a gene-specific manner in human monocytes. Eur J Immunol 45:287\u2013297","journal-title":"Eur J Immunol"},{"key":"11514_CR49","doi-asserted-by":"crossref","unstructured":"Liu J, Zhang C, Wang J et al (2022) A class I HDAC inhibitor BG45 alleviates cognitive impairment through the CaMKII\/ITPKA\/Ca(2+) signaling pathway. Pharmaceuticals 15:1481","DOI":"10.3390\/ph15121481"},{"key":"11514_CR50","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/1471-2164-13-709","volume":"13","author":"G Majumdar","year":"2012","unstructured":"Majumdar G, Adris P, Bhargava N, Chen H, Raghow R (2012) Pan-histone deacetylase inhibitors regulate signaling pathways involved in proliferative and pro-inflammatory mechanisms in H9c2 cells. BMC Genomics 13:709","journal-title":"BMC Genomics"},{"key":"11514_CR51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/15592294.2018.1481703","volume":"13","author":"JE Kirkpatrick","year":"2018","unstructured":"Kirkpatrick JE, Kirkwood KL, Woster PM (2018) Inhibition of the histone demethylase KDM4B leads to activation of KDM1A, attenuates bacterial-induced pro-inflammatory cytokine release, and reduces osteoclastogenesis. Epigenetics 13:557\u2013572","journal-title":"Epigenetics"},{"key":"11514_CR52","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1101\/gad.1333905","volume":"19","author":"S Huang","year":"2005","unstructured":"Huang S, Litt M, Felsenfeld G (2005) Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications. Genes Dev 19:1885\u20131893","journal-title":"Genes Dev"},{"key":"11514_CR53","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jmb.2008.01.044","volume":"377","author":"PO Hassa","year":"2008","unstructured":"Hassa PO, Covic M, Bedford MT, Hottiger MO (2008) Protein arginine methyltransferase 1 coactivates NF-kappaB-dependent gene expression synergistically with CARM1 and PARP1. J Mol Biol 377:668\u2013678","journal-title":"J Mol Biol"},{"key":"11514_CR54","doi-asserted-by":"crossref","unstructured":"Kim E, Jang J, Park JG, Kim KH, Yoon K, Yoo BC (2020) Protein Arginine Methyltransferase 1 (PRMT1) Selective Inhibitor, TC-E 5003, Has Anti-Inflammatory Properties in TLR4 Signaling. 21:3058","DOI":"10.3390\/ijms21093058"},{"key":"11514_CR55","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1073\/pnas.1522372113","volume":"113","author":"A Reintjes","year":"2016","unstructured":"Reintjes A, Fuchs JE, Kremser L et al (2016) Asymmetric arginine dimethylation of RelA provides a repressive mark to modulate TNF\u03b1\/NF-\u03baB response. Proc Natl Acad Sci USA 113:4326\u20134331","journal-title":"Proc Natl Acad Sci USA"},{"key":"11514_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078832","volume":"8","author":"J Hu","year":"2013","unstructured":"Hu J, Wang G, Liu X, Zhou L, Jiang M, Yang L (2013) Polo-like kinase 1 (PLK1) is involved in toll-like receptor (TLR)-mediated TNF-\u03b1 production in monocytic THP-1 cells. PLoS One 8:e78832","journal-title":"PLoS One"},{"key":"11514_CR57","doi-asserted-by":"publisher","DOI":"10.1172\/JCI162129","author":"M Baldrighi","year":"2023","unstructured":"Baldrighi M, Doreth C, Li Y et al (2023) PLK1 inhibition dampens NLRP3 inflammasome\u2013elicited response in inflammatory disease models. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI162129","journal-title":"J Clin Invest"},{"key":"11514_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.931493","volume":"10","author":"SYX Tan","year":"2022","unstructured":"Tan SYX, Zhang J, Tee WW (2022) Epigenetic regulation of inflammatory signaling and inflammation-induced cancer. Front Cell Dev Biol 10:931493","journal-title":"Front Cell Dev Biol"},{"key":"11514_CR59","doi-asserted-by":"crossref","unstructured":"Li X, Shao M, Zeng X, Qian P, Huang H (2021) Correction: Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy. 6:403","DOI":"10.1038\/s41392-021-00815-w"},{"key":"11514_CR60","doi-asserted-by":"publisher","first-page":"E944","DOI":"10.1073\/pnas.1110156109","volume":"109","author":"K Schroder","year":"2012","unstructured":"Schroder K, Irvine KM, Taylor MS et al (2012) Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages. Proc Natl Acad Sci U S A 109:E944\u2013953","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11514_CR61","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","volume":"172","author":"J Mestas","year":"2004","unstructured":"Mestas J, Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172:2731\u20132738","journal-title":"J Immunol"},{"key":"11514_CR62","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nri3088","volume":"11","author":"T Lawrence","year":"2011","unstructured":"Lawrence T, Natoli G (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11:750\u2013761","journal-title":"Nat Rev Immunol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11514-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11514-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11514-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:04:06Z","timestamp":1770131046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11514-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11514"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11514-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This research article does not involve human or animal participants; therefore, ethical approval, informed consent to participate, and consent to publish are not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"354"}}